Novel Stem Cell Therapies for Applications to Wound Healing and Tissue Repair
Ayman Grada, MD, Research Fellow, Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, Vincent Falanga, MD, FACP, Program Director and Vice-Chair of Research, Department of Dermatology and Biochemistry, Boston University School of Medicine, Boston, Massachusetts

Oct-2016 - 747

 

Autologous Adipose Derived Regenerative Cells: A Platform for Therapeutic Applications
Steven Kesten, MD, Chief Medical Officer, Cytori Therapeutics, Inc., San Diego, California, John K. Fraser, PhD, Chief Scientist, Cytori Therapeutics, Inc., San Diego, California

July-2016 - 751

The Effectiveness of Topical Polyhexamethylene Biguanide (PHMB) Agents for the Treatment of Chronic Wounds: A Systematic Review
Eliot To, MClSc-WH, DCH, Chiropodist, St. Joseph’s Health Centre, Toronto, Ontario, Rebecca Dyck, RN, MClSc-WH, St. Catharines, Ontario, Stephanie Gerber, RN, MClSc-WH, Chronic Disease Manager, Fort Frances Family Health Team, Fort Frances, Ontario, Shauna Kadavil, MClSc-WH, BScOT(C), Occupational Therapist, South Health Campus, Calgary, Alberta, Kevin Y. Woo, PhD, RN, FAPWCA, Assistant Professor, School of Nursing, Faculty of Health Sciences, Queen’s University, Kingston, Ontario

Sep 2016 -720

 

Aneuploidy and Tetraploidy as Distinct Patterns During Melanomagenesis
Julia Escandon, MD, PhD Candidate, Sheila and David Fuente Cancer Biology Graduate Program, Sylvester Comprehensive Cancer Center, Department of Dermatology and Cutaneous Surgery, University of Miami – Miller School of Medicine, Miami, Florida, Lauren King, MS, Field Application Specialist, Cellay, Inc., Cambridge, Massachusetts, Reuven Blobstein, BS, Medical Student, Department of Dermatology and Cutaneous Surgery, University of Miami – Miller School of Medicine, Miami, Florida, Mark S. Eller, PhD, Senior Scientist, Sheila and David Fuente Cancer Biology, Graduate Program, Sylvester Comprehensive Cancer Center, University of Miami – Miller School of Medicine, Miami, Florida, Joan Aurich-Costa, PhD, Chief Scientific Officer, Cellay, Inc., Cambridge, Massachusetts

July-2016 - 734

 

The EXPLORE Trial: A Feasibility Study Using Fluorescence Angiography to Evaluate Perfusion in the Oxygen-Rich Environment
Jonathan F. Arnold, MD, ABPM-UHM, CWS-P, Medical Director, Great River Wound and Hyperbaric Medicine Clinic, Great River Medical Center, West Burlington, Iowa, Melissa Roscum, RN, BSN, CHT, CWCA, Staff Nurse, Great River Wound and Hyperbaric Medicine Clinic, Great River Medical Center, West Burlington, Iowa

Oct-2016 - 763

 

Application of the Prevena™ Incision Management System Following Complex Ventral Hernia Repairs with Abdominal Wall Reconstruction

Sala Abdalla, BSc, MBBS, MRCS, Specialist Registrar, Department of General Surgery, Queen Elizabeth Hospital, Woolwich, London, Rachel Rolph, MBBS, MRCS, Specialist Registrar, Department of General Surgery, Queen Elizabeth Hospital, Woolwich, London, Anjali Rampersad, MBBS, Foundation Year 1 Doctor, Department of General Surgery, Queen Elizabeth Hospital, Woolwich, London, Grisma Patel, MBBS, Foundation Year 1 Doctor, Department of General Surgery, Queen Elizabeth Hospital, Woolwich, London, Tayo Oke, MBBS, M.Med.Sci, FRCS (Gen), FRCS (Ed), Consultant/Colorectal Surgeon, Department of General Surgery, Queen Elizabeth Hospital, Woolwich, London, UK

 

Jul-2016 - 741, PM ID : 27392324

0.1% Polyhexanide-Betaine Solution as an Adjuvant in a Case-Series of Chronic Wounds
Michael Moore, MD, FACS, FACCWS, Medical Director, Wound Institute and Research Center, Dunmore, Pennsylvania, Nanci Dobson, RN, CCRP, CWCA, Clinical Research Coordinator, Wound Institute and, Research Center, Dunmore, Pennsylvania, Wes Cetnarowski, MD, Senior Vice President Scientific Affairs and Chief Medical Officer, B. Braun Medical Inc., Allentown, Pennsylvania

Oct-2016 - 790